Correlation Between Processa Pharmaceuticals and Scopus Biopharma
Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Scopus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Scopus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Processa Pharmaceuticals and Scopus Biopharma, you can compare the effects of market volatilities on Processa Pharmaceuticals and Scopus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Scopus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Scopus Biopharma.
Diversification Opportunities for Processa Pharmaceuticals and Scopus Biopharma
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Processa and Scopus is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Scopus Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scopus Biopharma and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Scopus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scopus Biopharma has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Scopus Biopharma go up and down completely randomly.
Pair Corralation between Processa Pharmaceuticals and Scopus Biopharma
Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the Scopus Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Processa Pharmaceuticals is 2.08 times less risky than Scopus Biopharma. The stock trades about -0.02 of its potential returns per unit of risk. The Scopus Biopharma is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 25.00 in Scopus Biopharma on September 3, 2024 and sell it today you would lose (15.00) from holding Scopus Biopharma or give up 60.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 7.88% |
| Values | Daily Returns |
Processa Pharmaceuticals vs. Scopus Biopharma
Performance |
| Timeline |
| Processa Pharmaceuticals |
| Scopus Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Processa Pharmaceuticals and Scopus Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Processa Pharmaceuticals and Scopus Biopharma
The main advantage of trading using opposite Processa Pharmaceuticals and Scopus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Scopus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scopus Biopharma will offset losses from the drop in Scopus Biopharma's long position.| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
| Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |